These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 21422921

  • 41. A novel CFHR5 mutation associated with C3 glomerulonephritis in a Turkish girl.
    Besbas N, Gulhan B, Gucer S, Korkmaz E, Ozaltin F.
    J Nephrol; 2014 Aug; 27(4):457-60. PubMed ID: 24536001
    [Abstract] [Full Text] [Related]

  • 42. Complement in glomerular diseases.
    Tan Y, Zhao MH.
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():11-15. PubMed ID: 30298653
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Eculizumab and recurrent C3 glomerulonephritis.
    Gurkan S, Fyfe B, Weiss L, Xiao X, Zhang Y, Smith RJ.
    Pediatr Nephrol; 2013 Oct; 28(10):1975-81. PubMed ID: 23689905
    [Abstract] [Full Text] [Related]

  • 45. Hyperfunctional complement C3 promotes C5-dependent atypical hemolytic uremic syndrome in mice.
    Smith-Jackson K, Yang Y, Denton H, Pappworth IY, Cooke K, Barlow PN, Atkinson JP, Liszewski MK, Pickering MC, Kavanagh D, Cook HT, Marchbank KJ.
    J Clin Invest; 2019 Mar 01; 129(3):1061-1075. PubMed ID: 30714990
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Complement activation in diseases presenting with thrombotic microangiopathy.
    Meri S.
    Eur J Intern Med; 2013 Sep 01; 24(6):496-502. PubMed ID: 23743117
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases.
    Blanc C, Togarsimalemath SK, Chauvet S, Le Quintrec M, Moulin B, Buchler M, Jokiranta TS, Roumenina LT, Fremeaux-Bacchi V, Dragon-Durey MA.
    J Immunol; 2015 Jun 01; 194(11):5129-38. PubMed ID: 25917093
    [Abstract] [Full Text] [Related]

  • 50. [Complement system regulation and C3 glomerulopathy].
    Xiao HJ, He RJ.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr 18; 45(2):323-6. PubMed ID: 23591359
    [Abstract] [Full Text] [Related]

  • 51. C3 glomerulopathy and current dilemmas.
    Ito N, Ohashi R, Nagata M.
    Clin Exp Nephrol; 2017 Aug 18; 21(4):541-551. PubMed ID: 27878657
    [Abstract] [Full Text] [Related]

  • 52. Dominant C3 glomerulopathy: new roles for an old actor in renal pathology.
    Pirozzi N, Stoppacciaro A, Menè P.
    J Nephrol; 2018 Aug 18; 31(4):503-510. PubMed ID: 29151252
    [Abstract] [Full Text] [Related]

  • 53. C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial.
    Ruggenenti P, Daina E, Gennarini A, Carrara C, Gamba S, Noris M, Rubis N, Peraro F, Gaspari F, Pasini A, Rigotti A, Lerchner RM, Santoro D, Pisani A, Pasi A, Remuzzi G, EAGLE Study Group.
    Am J Kidney Dis; 2019 Aug 18; 74(2):224-238. PubMed ID: 30929851
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome.
    Józsi M, Reuter S, Nozal P, López-Trascasa M, Sánchez-Corral P, Prohászka Z, Uzonyi B.
    Immunol Lett; 2014 Aug 18; 160(2):163-71. PubMed ID: 24491679
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. C3 glomerulonephritis secondary to mutations in factors H and I: rapid recurrence in deceased donor kidney transplant effectively treated with eculizumab.
    Garg N, Zhang Y, Nicholson-Weller A, Khankin EV, Borsa NG, Meyer NC, McDermott S, Stillman IE, Rennke HG, Smith RJ, Pavlakis M.
    Nephrol Dial Transplant; 2018 Dec 01; 33(12):2260-2265. PubMed ID: 29370420
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.